NYSE American - Delayed Quote USD

Catheter Precision, Inc. (VTAK)

0.5987 -0.0088 (-1.45%)
At close: 3:59 PM EDT
Loading Chart for VTAK
DELL
  • Previous Close 0.6075
  • Open 0.5787
  • Bid 0.5600 x 1000
  • Ask 0.6095 x 4000
  • Day's Range 0.5710 - 0.6485
  • 52 Week Range 0.3400 - 1.3200
  • Volume 87,107
  • Avg. Volume 37,563
  • Market Cap (intraday) 4.534M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 0.05
  • EPS (TTM) 11.3000
  • Earnings Date Mar 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.10

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

www.catheterprecision.com

14

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VTAK

Performance Overview: VTAK

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VTAK
49.67%
S&P 500
10.00%

1-Year Return

VTAK
52.10%
S&P 500
27.22%

3-Year Return

VTAK
99.66%
S&P 500
27.58%

5-Year Return

VTAK
99.99%
S&P 500
86.59%

Compare To: VTAK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VTAK

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    4.60M

  • Enterprise Value

    3.36M

  • Trailing P/E

    0.05

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.23

  • Price/Book (mrq)

    0.25

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -15.36%

  • Return on Equity (ttm)

    -25.18%

  • Revenue (ttm)

    439k

  • Net Income Avi to Common (ttm)

    -6.85M

  • Diluted EPS (ttm)

    11.3000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.49M

  • Total Debt/Equity (mrq)

    1.37%

  • Levered Free Cash Flow (ttm)

    -5.71M

Research Analysis: VTAK

Company Insights: VTAK

Research Reports: VTAK

People Also Watch